Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, March 29, 2024 · 699,623,665 Articles · 3+ Million Readers

Recent Analysis Shows SBA Communications, AMAG Pharmaceuticals, Galectin Therapeutics, Xilinx, J.B. Hunt Transport Services, and Southern Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SBA Communications Corporation (NASDAQ:SBAC), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Galectin Therapeutics Inc. (NASDAQ:GALT), Xilinx, Inc. (NASDAQ:XLNX), J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT), and Southern Company (NYSE:SO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SBAC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SBAC
AMAG DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMAG
GALT DOWNLOAD: http://Fundamental-Markets.com/register/?so=GALT
XLNX DOWNLOAD: http://Fundamental-Markets.com/register/?so=XLNX
JBHT DOWNLOAD: http://Fundamental-Markets.com/register/?so=JBHT
SO DOWNLOAD: http://Fundamental-Markets.com/register/?so=SO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine SBA Communications Corporation (NASDAQ:SBAC), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Galectin Therapeutics Inc. (NASDAQ:GALT), Xilinx, Inc. (NASDAQ:XLNX), J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT), and Southern Company (NYSE:SO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 14th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SBA COMMUNICATIONS CORPORATION (SBAC) REPORT OVERVIEW

SBA Communications' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, SBA Communications reported revenue of $433.95MM vs $411.32MM (up 5.50%) and basic earnings per share $0.41 vs -$0.12. For the twelve months ended December 31st, 2016 vs December 31st, 2015, SBA Communications reported revenue of $1,633.13MM vs $1,638.47MM (down 0.33%) and basic earnings per share $0.61 vs -$1.37. SBA Communications is expected to report earnings on February 26th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.04. The estimated EPS forecast for the next fiscal year is $1.33 and is expected to report on February 26th, 2018.

To read the full SBA Communications Corporation (SBAC) report, download it here: http://Fundamental-Markets.com/register/?so=SBAC

-----------------------------------------

AMAG PHARMACEUTICALS, INC. (AMAG) REPORT OVERVIEW

AMAG Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, AMAG Pharmaceuticals reported revenue of $153.74MM vs $143.78MM (up 6.93%) and basic earnings per share -$4.31 vs $0.47. For the twelve months ended December 31st, 2016 vs December 31st, 2015, AMAG Pharmaceuticals reported revenue of $532.09MM vs $418.28MM (up 27.21%) and basic earnings per share -$0.07 vs $1.04. AMAG Pharmaceuticals is expected to report earnings on February 13th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$2.52 and is expected to report on February 13th, 2018.

To read the full AMAG Pharmaceuticals, Inc. (AMAG) report, download it here: http://Fundamental-Markets.com/register/?so=AMAG

-----------------------------------------

GALECTIN THERAPEUTICS INC. (GALT) REPORT OVERVIEW

Galectin Therapeutics' Recent Financial Performance

Galectin Therapeutics is expected to report earnings on March 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is -$0.48 and is expected to report on March 27th, 2018.

To read the full Galectin Therapeutics Inc. (GALT) report, download it here: http://Fundamental-Markets.com/register/?so=GALT

-----------------------------------------

XILINX, INC. (XLNX) REPORT OVERVIEW

Xilinx's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Xilinx reported revenue of $631.19MM vs $585.69MM (up 7.77%) and basic earnings per share $0.05 vs $0.57 (down 91.23%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, Xilinx reported revenue of $2,349.33MM vs $2,213.88MM (up 6.12%) and basic earnings per share $2.47 vs $2.14 (up 15.42%). Xilinx is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.57. The estimated EPS forecast for the next fiscal year is $2.89 and is expected to report on April 25th, 2018.

To read the full Xilinx, Inc. (XLNX) report, download it here: http://Fundamental-Markets.com/register/?so=XLNX

-----------------------------------------

J.B. HUNT TRANSPORT SERVICES, INC. (JBHT) REPORT OVERVIEW

J.B. Hunt Transport Services' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, J.B. Hunt Transport Services reported revenue of $1,843.33MM vs $1,690.66MM (up 9.03%) and basic earnings per share $0.92 vs $0.97 (down 5.15%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, J.B. Hunt Transport Services reported revenue of $6,555.46MM vs $6,187.65MM (up 5.94%) and basic earnings per share $3.84 vs $3.69 (up 4.07%). J.B. Hunt Transport Services is expected to report earnings on April 16th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.92. The estimated EPS forecast for the next fiscal year is $6.16 and is expected to report on January 17th, 2019.

To read the full J.B. Hunt Transport Services, Inc. (JBHT) report, download it here: http://Fundamental-Markets.com/register/?so=JBHT

-----------------------------------------

SOUTHERN COMPANY (SO) REPORT OVERVIEW

Southern's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Southern reported revenue of $6,201.00MM vs $6,264.00MM (down 1.01%) and basic earnings per share $1.07 vs $1.18 (down 9.32%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Southern reported revenue of $19,896.00MM vs $17,489.00MM (up 13.76%) and basic earnings per share $2.57 vs $2.60 (down 1.15%). Southern is expected to report earnings on February 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.24. The estimated EPS forecast for the next fiscal year is $3.00 and is expected to report on February 21st, 2018.

To read the full Southern Company (SO) report, download it here: http://Fundamental-Markets.com/register/?so=SO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release